InvestorsHub Logo

Steges

04/14/14 2:29 PM

#103407 RE: AJSails #103403

Very nicely done. Thanks for putting this together.

heidibrown

04/14/14 2:33 PM

#103409 RE: AJSails #103403

Thank you AJ!

imtheking

04/14/14 2:42 PM

#103412 RE: AJSails #103403

I think 12 Million will be low for the ANDA's and I don't think the whole A/S will come close to hitting the market. This is very conservative and shows how much potential this company has. Great post. Thanks.

Gman24

04/14/14 2:42 PM

#103413 RE: AJSails #103403

This a great post... I'm still shaking from reading the possibilities....Thanks for sharing...

greentexas

04/14/14 3:23 PM

#103427 RE: AJSails #103403

Great post!

It's all good but I especially like the part where it says "we are very pleased" concerning bioequivalent tests.

Bioequivalence [ BE ] , is like a stage of an algebra problem. You really can't progress further until you complete it.

They did...and Will

Cosh Dawg

04/14/14 4:16 PM

#103446 RE: AJSails #103403

Great thing about these estimated PPSs is they also use a conservative P/E of 15. Some biotechs have P/Es well over 70.

http://biz.yahoo.com/ic/ll/515per.html

Based on the market's reaction to these products, once they are released there's no telling where the ceiling is for little ol' Elite.

dr_lowenstein

04/14/14 6:42 PM

#103489 RE: AJSails #103403

WOW!!!!!! Is there one, just one, independent analyst on the planet that believes this is the real potential for elite. notice the lack of question mark lol lol

mrwrn2010

04/14/14 10:28 PM

#103559 RE: AJSails #103403

Stickied. Good work AJ! No brainer at these levels.

BS Sifter

04/14/14 10:29 PM

#103561 RE: AJSails #103403

This is clearly a pump and dump. I don't see any potential here.


Ask LPC, they would certainly agree.

Stock_Trader

04/15/14 1:30 AM

#103609 RE: AJSails #103403

Thanks AJ for crunching the #'s!!

Thinking on a global market ... since ELTP undoubtedly will end up in at least the Canadian and European markets ... here's some even more astounding #'s I found that could likely at least double, if not triple, the size of your "pain market" values and thus double or triple all your share price values .... ?

"In 2010, the global pain management market was worth approximately $28.6 billion, representing a compound annual growth rate (CAGR) of 5.3% between 2002 and 2010. By 2017, the global pain management market is estimated to reach $35.1 billion"

http://www.marketresearch.com/GBI-Research-v3759/Pain-Management-Therapeutics-Price-Competition-6690800/